{"meshTags":["Adenocarcinoma","Male","Korea","Middle Aged","Aged","Adult","Antineoplastic Agents","Antibodies, Monoclonal, Humanized","DNA Mutational Analysis","Humans","Carcinoma, Non-Small-Cell Lung","Female","Receptor, ErbB-2","Lung Neoplasms","Antibodies, Monoclonal","Trastuzumab"],"meshMinor":["Adenocarcinoma","Male","Korea","Middle Aged","Aged","Adult","Antineoplastic Agents","Antibodies, Monoclonal, Humanized","DNA Mutational Analysis","Humans","Carcinoma, Non-Small-Cell Lung","Female","Receptor, ErbB-2","Lung Neoplasms","Antibodies, Monoclonal","Trastuzumab"],"genes":["ERBB2 kinase domain"],"publicationTypes":["Letter","Research Support, Non-U.S. Gov\u0027t"],"title":"Absence of the ERBB2 kinase domain mutation in lung adenocarcinomas in Korean patients.","pubmedId":"15825173"}